Arbutus Biopharma Corp (ABUS)

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 20, 2024

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $754,000 in Arbutus Biopharma Co. (NASDAQ:ABUS) - MarketBeat

Dec 20, 2024

Dec 16, 2024

Arbutus Biopharma's SWOT analysis: hepatitis B focus drives stock potential - Investing.com

Dec 16, 2024

Dec 16, 2024

Arbutus Biopharma (NASDAQ:ABUS) Shares Gap DownHere's Why - MarketBeat

Dec 16, 2024

Dec 14, 2024

Charles Schwab Investment Management Inc. Purchases 831,663 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - MarketBeat

Dec 14, 2024

Dec 08, 2024

Intech Investment Management LLC Takes Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 08, 2024

Dec 06, 2024

Large Shareholder Urges Warminster-based Arbutus to Seek Partners Instead of Selling More Stock - BUCKSCO.Today

Dec 06, 2024

Dec 06, 2024

Here’s Why Arbutus (ABUS) Surged in Q3 - Yahoo Finance

Dec 06, 2024

Dec 04, 2024

Arbutus Biopharma's SWOT analysis: focus on CHB treatment drives stock outlook - Investing.com

Dec 04, 2024

Dec 03, 2024

Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors - The Bakersfield Californian

Dec 03, 2024

Dec 03, 2024

Arbutus Biopharma's HBV Trial Hits 50% Cure Rate; Major Investor Urges Strategic Partnership - StockTitan

Dec 03, 2024

Dec 02, 2024

Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Update - MarketBeat

Dec 02, 2024

Dec 01, 2024

Arbutus Biopharma (STU:I9DN) 9-Day RSI : 39.19 (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 27, 2024

Principal Financial Group Inc. Reduces Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Nov 27, 2024

Nov 26, 2024

Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat - Yahoo Finance

Nov 26, 2024

Nov 25, 2024

Arbutus Biopharma (FRA:I9DN) Price-to-Operating-Cash-Flow : (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024

Nov 22, 2024

Arbutus Biopharma (STU:I9DN) Days Inventory : 0.00 (As of Sep. 2024) - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

Arbutus Biopharma (STU:I9DN) Long-Term Debt & Capital Lease Obligation : €0.88 Mil (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

Arbutus Biopharma (NASDAQ:ABUS) Earns "Buy" Rating from Chardan Capital - MarketBeat

Nov 20, 2024

Nov 18, 2024

HC Wainwright Reiterates Buy Rating for Arbutus Biopharma (NASDAQ:ABUS) - MarketBeat

Nov 18, 2024

Nov 17, 2024

Arbutus Biopharma’s Clinical Trial Shows Promise for Hepatitis B Treatment - MyChesCo

Nov 17, 2024

Nov 17, 2024

Arbutus Biopharma Announces Positive Data from Clinical Trials at AASLD – The Liver Meeting® 2024 - Defense World

Nov 17, 2024

Nov 17, 2024

Promising New Data from Hepatitis B Trial by Arbutus and Barinthus - MyChesCo

Nov 17, 2024

Nov 17, 2024

Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Down 16.0% in October - Defense World

Nov 17, 2024

Nov 16, 2024

ArriVent BioPharma Reports Advancements and Q3 2024 Financial Results - MyChesCo

Nov 16, 2024

Nov 16, 2024

Arbutus Biopharma to Showcase Innovations at Jefferies London Healthcare Conference - MyChesCo

Nov 16, 2024

Nov 15, 2024

Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Two Seas Capital LP Adjusts Stake in Arbutus Biopharma Corp - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Arbutus to Present at Jefferies London Healthcare Conference - Yahoo Finance

Nov 14, 2024

Nov 12, 2024

Creative Planning Raises Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Nov 12, 2024

Nov 11, 2024

HC Wainwright Has Negative Forecast for ABUS FY2024 Earnings - MarketBeat

Nov 11, 2024

Nov 11, 2024

HC Wainwright Expects Weaker Earnings for Arbutus Biopharma - Defense World

Nov 11, 2024

Nov 09, 2024

HC Wainwright Reaffirms “Buy” Rating for Arbutus Biopharma (NASDAQ:ABUS) - Defense World

Nov 09, 2024

Nov 08, 2024

Arbutus Biopharma 8-K Filing: Financial Results and Corporate Presentation Update - Defense World

Nov 08, 2024

Nov 08, 2024

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Nov 08, 2024

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Expected to Rise, Chardan Capital Analyst Says - Defense World

Nov 08, 2024

Nov 07, 2024

HC Wainwright Reaffirms Buy Rating for Arbutus Biopharma (NASDAQ:ABUS) - MarketBeat

Nov 07, 2024

Nov 07, 2024

Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: Promising Clinical Trials and ... By GuruFocus - Investing.com Canada

Nov 07, 2024

Nov 07, 2024

Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: Promising Clinical Trials and ... - Yahoo Finance

Nov 07, 2024

Nov 06, 2024

Arbutus Fades on Q4 Results - Baystreet.ca

Nov 06, 2024

Nov 06, 2024

Arbutus Biopharma earnings missed, revenue fell short of estimates - Investing.com

Nov 06, 2024

Nov 06, 2024

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Arbutus Biopharma Corp Q3 2024 Earnings: EPS Loss of $0.10 Meets Estimates, Revenue Falls Short at $1.3 Million - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Arbutus: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 06, 2024

Nov 06, 2024

Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

Nov 06, 2024

Oct 30, 2024

Arbutus Biopharma (ABUS) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024

Oct 23, 2024

Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Yahoo Finance

Oct 23, 2024

Oct 23, 2024

SG Americas Securities LLC Acquires New Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Oct 23, 2024

Oct 16, 2024

Arbutus Biopharma Target of Unusually High Options Trading (NASDAQ:ABUS) - MarketBeat

Oct 16, 2024

Oct 16, 2024

Arbutus Biopharma Corp (ABUS) Stock: A Year of Declines and Increases - The InvestChronicle

Oct 16, 2024

Oct 15, 2024

Arbutus Biopharma (NASDAQ:ABUS) Trading Up 5.7%Still a Buy? - MarketBeat

Oct 15, 2024